B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged - CISMeF
B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A RearrangedNCIt concept
Preferred Label : B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged;
NCIt synonyms : B-ALL with t(v;11q23.3)/KMT2A Rearranged; B Acute Lymphoblastic Leukemia with t(v;11q23.3); MLL Rearranged; B-Acute Lymphoblastic Leukemia with t(v;11q23.3); MLL Rearranged; B Acute Lymphoblastic Leukemia with t v 11q23 MLL Rearranged; B-Cell Acute Lymphoblastic Leukemia with t(v;11q23.3); MLL Rearranged; B-ALL with t(v;11q23.3); KMT2A Rearranged; B-Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged; B Acute Lymphoblastic Leukemia with KMT2A Rearrangement; B-Acute Lymphoblastic Leukemia with KMT2A Rearrangement;
NCIt definition : A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a
translocation between the KMT2A gene at 11q23.3 and another gene partner resulting
in the production of an KMT2A related fusion protein. It is the most commonly seen
leukemia in the pediatric population under the age of one year. The prognosis is unfavorable.;